Results 71 to 80 of about 89,275 (314)

Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database [PDF]

open access: yes, 2016
Objective To assess associations between different antidepressant treatments and rates of three cardiovascular outcomes (myocardial infarction, stroke or transient ischaemic attack, and arrhythmia) in people with depression.
Arthur, Antony   +5 more
core   +2 more sources

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman   +6 more
wiley   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale   +5 more
wiley   +1 more source

Antidepressant-induced sexual dysfunction

open access: yesSouth African Family Practice, 2009
Depression and sexual dysfunction are both common in the general population. When they co-exist, they have the potential to impact negatively on each other in a bidirectional manner.
Kim Outhoff
doaj   +1 more source

What's a brain: neuroanatomy and neurochemistry of anxiety disorders in dogs [PDF]

open access: yes, 2011
This review deals with the neurocircuitry of fear and anxiety disorders, with the focus on neuroanatomy and neurochemistry. This knowledge is required to correctly diagnose and treat dogs with anxiety-related behavioral disorders.
Audenaert, Kurt   +6 more
core   +1 more source

Prevalence and impact of prescribing cascades in community‐dwelling adults: Longitudinal analysis of the Irish longitudinal study on ageing (TILDA)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Prescribing cascades occur when medication is prescribed to prevent/treat the adverse effects of another medication and may be intentional/unintentional. This study examines the prevalence of nine prescribing cascades (ThinkCascades) in The Irish Longitudinal StuDy on Ageing (TILDA).
Ann Sinéad Doherty   +7 more
wiley   +1 more source

Drug interactions and possible serotonin syndrome in a patient with fibromyalgia

open access: yesVitae, 2014
Depression associated with fibromyalgia can be treated with selective serotonin reuptake inhibitors (SSRI) as fluoxetine, paroxetine or citalopram; or with serotonin–norepinephrine reuptake inhibitors (duloxetine or milnacipran).
Patricia de Carvalho MASTROIANNI   +2 more
doaj  

Selective serotonin reuptake inhibitors for fibromyalgia syndrome

open access: yesSão Paulo Medical Journal
BACKGROUND: Fibromyalgia is a clinically well-defined chronic condition with a biopsychosocial aetiology. Fibromyalgia is characterized by chronic widespread musculoskeletal pain, sleep problems, cognitive dysfunction, and fatigue. Patients often report
Brian Walitt   +4 more
doaj   +1 more source

Skin eruptions related with selective serotonin reuptake inhibitors

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: The aim of the present study was to provide clinical data regarding clinical and sociodemographic features of individuals who were admitted to our clinic for skin rash during treatment with selective serotonin reuptake inhibitors (SSRI ...
Ayse Suleyman   +3 more
doaj  

The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents

open access: yesIBRO Reports, 2019
This study was designed with the rational aim of discussing the emerging antidepressant agents that are likely to bring positive landmark, tremendous improvement and significant impact to the management of patients with depression disorders.
Olumuyiwa John Fasipe
doaj   +1 more source

Home - About - Disclaimer - Privacy